Noank, CT, United States of America

Wan F Lau


Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Wan F. Lau in Pharmacology

Introduction

Wan F. Lau is an accomplished inventor based in Noank, Connecticut, who has made significant contributions to the field of pharmacology. With a portfolio that includes four patents, she focuses on developing innovative solutions to treat inflammatory, autoimmune, and respiratory diseases.

Latest Patents

One of her most notable patents is for non-peptidyl inhibitors of VLA-4 dependent cell binding. This invention discloses a genus of non-peptidyl compounds that serve as VLA-4 inhibitors, proving useful in treating various inflammatory and autoimmune conditions. In addition, she holds a patent for modulators of chemokine receptor activity, specifically targeting bicyclic diamine compounds that act as antagonists for chemokine CCR2 and CCR3 receptors. These innovations have pharmaceutical applications in diseases associated with monocyte, lymphocyte, or leucocyte accumulation.

Career Highlights

Wan F. Lau is currently employed at Pfizer Corporation, a global leader in pharmaceutical research and development. Her work at this esteemed organization allows her to leverage her expertise in creating effective therapies that can address significant health challenges.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Allen Jacob Duplantier and Louis Stanley Chupak. These partnerships have undoubtedly enriched her research endeavors and contributed to her success in the field.

Conclusion

Wan F. Lau exemplifies the spirit of innovation within the pharmaceutical industry. Her patents reflect her commitment to advancing medical science and improving patient outcomes through effective treatment options. Her contributions continue to impact the landscape of pharmacological research and development positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…